• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[肝硬化患者腹水的预后意义]

[Prognostic significance of ascites in patients with liver cirrhosis].

作者信息

Brodanová M

机构信息

I. interní klinika 1. LF UK, Praha.

出版信息

Vnitr Lek. 1994 Nov;40(11):735-8.

PMID:7810099
Abstract

The author evaluates the prognostic importance of ascites in 100 patients with cirrhosis of the liver. The patients were followed up on a log-term basis in a hepatology clinic and the diagnosis was confirmed morphologically. Ascites developed at a time when marked objective and laboratory signs of chronic liver disease were present. Ascites was diagnosed by physical examination and verified by ultrasonography. It was treated by contemporary procedures. Survival of cirrhotic patients with ascites was unfavorable--50% survived one year, 38% two years, 17% three years, 15% four years and only 9% five years. Ascites is thus still a very adverse prognostic indicator for patients with cirrhosis.

摘要

作者评估了100例肝硬化患者腹水的预后重要性。这些患者在肝病诊所进行了长期随访,诊断经形态学证实。腹水在出现明显的慢性肝病客观体征和实验室检查结果时出现。腹水通过体格检查诊断,并经超声检查证实。采用当代方法进行治疗。肝硬化腹水患者的生存率不佳——50%存活1年,38%存活2年,17%存活3年,15%存活4年,仅9%存活5年。因此,腹水仍然是肝硬化患者非常不利的预后指标。

相似文献

1
[Prognostic significance of ascites in patients with liver cirrhosis].[肝硬化患者腹水的预后意义]
Vnitr Lek. 1994 Nov;40(11):735-8.
2
Survival and prognostic factors of cirrhotic patients with ascites: a study of 134 outpatients.肝硬化腹水患者的生存及预后因素:134例门诊患者的研究
Am J Gastroenterol. 1993 Apr;88(4):514-9.
3
Prognosis assessment of cirrhotic patients with refractory ascites treated with a peritoneovenous shunt.经颈静脉肝内门体分流术治疗肝硬化顽固性腹水患者的预后评估
Am J Gastroenterol. 1995 Dec;90(12):2097-102.
4
Predictors of clinical response to transjugular intrahepatic portosystemic shunt (TIPS) in cirrhotic patients with refractory ascites.肝硬化难治性腹水患者经颈静脉肝内门体分流术(TIPS)临床反应的预测因素
Am J Gastroenterol. 1999 May;94(5):1361-5. doi: 10.1111/j.1572-0241.1999.01112.x.
5
Influence of long-term administration of serum albumin on the prognosis of liver cirrhosis in man.长期输注血清白蛋白对人类肝硬化预后的影响。
Tokai J Exp Clin Med. 1983 Jan;8(1):71-8.
6
Prognostic factors for long-term survival in cirrhotic patients after the first episode of liver decompensation.肝硬化患者首次肝失代偿发作后长期生存的预后因素。
Ital J Gastroenterol Hepatol. 1997 Feb;29(1):38-46.
7
Hepatic tissue endothelin-1 levels in chronic liver disease correlate with disease severity and ascites.慢性肝病患者肝组织中内皮素-1水平与疾病严重程度及腹水相关。
Am J Gastroenterol. 2000 Jan;95(1):199-203. doi: 10.1111/j.1572-0241.2000.01684.x.
8
[Viral liver cirrhosis: natural course, pathogenesis and clinical implications of the complications].[病毒性肝硬化:自然病程、发病机制及并发症的临床意义]
Ann Ital Med Int. 1996 Oct;11 Suppl 2:23S-29S.
9
Clinical characteristics and outcome of patients with cirrhosis and refractory ascites.肝硬化合并顽固性腹水患者的临床特征及预后
Liver Int. 2004 Oct;24(5):457-64. doi: 10.1111/j.1478-3231.2004.0991.x.
10
[Predictive analysis of the response to treatment with diuretics of patients with liver cirrhosis and ascites].[肝硬化腹水患者利尿剂治疗反应的预测分析]
Rev Esp Enferm Dig. 1995 Dec;87(12):859-64.